David Allen Stamler insider trades

Open-market stock purchases and sales by David Allen Stamler, Chief Executive Officer at Alterity Therapeutics Ltd, from SEC Form 4 filings since Aug 31, 2026.

Recent trades

DateStockTradeValue
Aug 31, 2026ATHE Alterity Therapeutics LtdBought$23.8K

Companies traded

  • ATHE Alterity Therapeutics Ltd: 1 buy, last Aug 31, 2026

Get free alerts when David Allen Stamler files a new trade →